Brief: Maxigen Biotech product Formaderm Charming Dermal Filler Injection receives TFDA approval for marketing
10/05/2018 11:59
May 10 (Reuters) - Maxigen Biotech Inc 1783.TW
* Says its product Formaderm Charming Dermal Filler
Injection
receives TFDA approval for marketing
Source text in Chinese: https://goo.gl/zqejNP
Further company coverage: 1783.TW
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Maxigen Biotech
See all newsInsurer MBIA hits over 6-month high after KBW upgrades to 'outperform'
Brief: Maxigen Biotech to pay dividend on Aug. 24
Brief: Maxigen Biotech product Formaderm Charming Dermal Filler Injection receives TFDA approval for marketing
Brief: Maxigen Biotech announces no dividend payment for 2016
Brief: Maxigen Biotech gets marketing approval for ArtiBest Intra-articular Injection from TFDA